{"id":12493,"date":"2025-07-31T15:03:01","date_gmt":"2025-07-31T13:03:01","guid":{"rendered":"https:\/\/www.kliinikum.ee\/yhendlabor\/?page_id=12493"},"modified":"2025-12-11T17:29:20","modified_gmt":"2025-12-11T15:29:20","slug":"lamotrigiin-sp-lamotr","status":"publish","type":"page","link":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/lamotrigiin-sp-lamotr\/","title":{"rendered":"Lamotrigiin (S,P-Lamotr)"},"content":{"rendered":"\n<p><em>Kliinilise keemia ja laboratoorse hematoloogia osakond<\/em><\/p>\n\n\n\n<p><strong>Lamotrigiin <\/strong>on laia toimespektriga krambivastane ravim, mida kasutatakse partsiaalsete ja generaliseerunud hoogudega epilepsia ning Lennoxi-Gastaut\u2019 s\u00fcndroomiga kaasnevate epileptiliste hoogude ravis. Lamotrigiin on n\u00e4idustatud ka t\u00e4iskasvanute bipolaarse meeleoluh\u00e4ire depressiivse faasi prof\u00fclaktikaks.<\/p>\n\n\n\n<p>Suukaudsel manustamisel imendub ravim kiiresti ja praktiliselt t\u00e4ielikult. Maksimaalne kontsentratsioon veres saabub umbes 2\u20133 tunni jooksul p\u00e4rast suukaudset manustamist. Plasmas on 55% lamotrigiinist seotud valkudega, metabolism toimub maksas ning eliminatsioon gl\u00fckuroniseeritud kujul neerude kaudu. Ravimi keskmine poolv\u00e4\u00e4rtusaeg tervetel t\u00e4iskasvanutel on 24\u201335 tundi. Regulaarsel manustamisel saavutatakse t\u00e4iskasvanutel stabiilne ravimi tase veres 3\u20136 \u00f6\u00f6p\u00e4eva jooksul peale ravi alustamist. Lamotrigiin indutseerib m\u00f5\u00f5dukalt enda metabolismi, mis v\u00e4hendab tema poolv\u00e4\u00e4rtusaega tasakaaluolekus kuni 25%. Karbamasepiini, fen\u00fctoiini, fenobarbitaali ja primidooni samaaegne kasutamine kiirendab lamotrigiini metabolismi, kuid valproaadiga samaaegsel manustamisel aeglustub metabolism kaks korda. Sagedasemad toksilised n\u00e4hud lamotrigiini \u00fcleannustamisel on n\u00fcstagm, ataksia, nahal\u00f6\u00f6bed, n\u00e4gemis- ja teadvush\u00e4ired.<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Uuritav materjal, selle v\u00f5tmine, saatmine ja s\u00e4ilitamine<\/strong><\/p>\n\n\n\n<p>Proov tuleb v\u00f5tta vahetult enne j\u00e4rgmise ravimiannuse manustamist!<\/p>\n\n\n\n<figure class=\"wp-block-table is-style-stripes\"><table width=\"100%\"><tbody><tr><td width=\"1%\"><\/td><td width=\"15%\"><strong>Katsuti<\/strong><\/td><td width=\"84%\">K2E\/K3E-katsuti (lilla kork)<\/td><\/tr><tr><td><\/td><td><strong>Kogus<\/strong><\/td><td>~1 mL plasmat<\/td><\/tr><tr><td><\/td><td><strong>S\u00e4ilivus<\/strong><\/td><td>Plasma +4 \u00b0C \u00fcks \u00f6\u00f6p\u00e4ev, \u201320 \u00b0C pikemat aega<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Anal\u00fc\u00fcsi tegemise aeg:<\/strong> kaks korda n\u00e4dalas<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Anal\u00fc\u00fcsimeetod: <\/strong>vedelikkromatograafia-massispektromeetria (LC-MS\/MS)<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><strong>Referentsv\u00e4\u00e4rtused<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-table\"><table width=\"100%\"><tbody><tr><td width=\"1%\"><\/td><td width=\"30%\"><strong>\u2265 18 a<\/strong><\/td><td width=\"37%\">Terapeutiline kontsentratsioon<\/td><td width=\"32%\">3,0\u201315,0 \u03bcg\/mL<\/td><\/tr><tr><td><\/td><td>&nbsp;<\/td><td>Toksiline kontsentratsioon<\/td><td>&gt; 20,0 \u03bcg\/mL<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"has-medium-font-size\"><strong>N\u00e4idustus ja kliiniline t\u00e4hendus<\/strong><\/p>\n\n\n\n<p>Lamotrigiinravi j\u00e4lgimine. Optimaalse raviskeemi leidmine ja kontroll, ravimim\u00fcrgistuse diagnostika.<\/p>\n\n\n\n<p>Koostajad: Jelena Beljantseva, Eliise-Rosalinda Ude<br>Muudetud 20.11.2023<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Kliinilise keemia ja laboratoorse hematoloogia osakond Lamotrigiin on laia toimespektriga krambivastane ravim, mida kasutatakse partsiaalsete ja generaliseerunud hoogudega epilepsia ning Lennoxi-Gastaut\u2019 s\u00fcndroomiga kaasnevate epileptiliste hoogude ravis. Lamotrigiin on n\u00e4idustatud ka t\u00e4iskasvanute bipolaarse meeleoluh\u00e4ire depressiivse faasi prof\u00fclaktikaks. Suukaudsel manustamisel imendub ravim kiiresti ja praktiliselt t\u00e4ielikult. Maksimaalne kontsentratsioon veres saabub umbes 2\u20133 tunni jooksul p\u00e4rast suukaudset manustamist. [&hellip;]<\/p>\n","protected":false},"author":38,"featured_media":0,"parent":7301,"menu_order":15,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_uag_custom_page_level_css":"","footnotes":""},"class_list":["post-12493","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lamotrigiin (S,P-Lamotr) - \u00dchendlabor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/lamotrigiin-sp-lamotr\/\" \/>\n<meta property=\"og:locale\" content=\"et_EE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lamotrigiin (S,P-Lamotr) - \u00dchendlabor\" \/>\n<meta property=\"og:description\" content=\"Kliinilise keemia ja laboratoorse hematoloogia osakond Lamotrigiin on laia toimespektriga krambivastane ravim, mida kasutatakse partsiaalsete ja generaliseerunud hoogudega epilepsia ning Lennoxi-Gastaut\u2019 s\u00fcndroomiga kaasnevate epileptiliste hoogude ravis. Lamotrigiin on n\u00e4idustatud ka t\u00e4iskasvanute bipolaarse meeleoluh\u00e4ire depressiivse faasi prof\u00fclaktikaks. Suukaudsel manustamisel imendub ravim kiiresti ja praktiliselt t\u00e4ielikult. Maksimaalne kontsentratsioon veres saabub umbes 2\u20133 tunni jooksul p\u00e4rast suukaudset manustamist. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/lamotrigiin-sp-lamotr\/\" \/>\n<meta property=\"og:site_name\" content=\"\u00dchendlabor\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-11T15:29:20+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/ravimiseire-uuringud\\\/lamotrigiin-sp-lamotr\\\/\",\"url\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/ravimiseire-uuringud\\\/lamotrigiin-sp-lamotr\\\/\",\"name\":\"Lamotrigiin (S,P-Lamotr) - \u00dchendlabor\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/#website\"},\"datePublished\":\"2025-07-31T13:03:01+00:00\",\"dateModified\":\"2025-12-11T15:29:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/ravimiseire-uuringud\\\/lamotrigiin-sp-lamotr\\\/#breadcrumb\"},\"inLanguage\":\"et\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/ravimiseire-uuringud\\\/lamotrigiin-sp-lamotr\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/ravimiseire-uuringud\\\/lamotrigiin-sp-lamotr\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"K\u00e4siraamat\",\"item\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Ravimiseire uuringud\",\"item\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/kasiraamat\\\/ravimiseire-uuringud\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Lamotrigiin (S,P-Lamotr)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/#website\",\"url\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/\",\"name\":\"\u00dchendlabor\",\"description\":\"Hoolivus, Uuendusmeelsus, P\u00e4devus ja Usaldusv\u00e4\u00e4rsus\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.kliinikum.ee\\\/yhendlabor\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"et\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lamotrigiin (S,P-Lamotr) - \u00dchendlabor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/lamotrigiin-sp-lamotr\/","og_locale":"et_EE","og_type":"article","og_title":"Lamotrigiin (S,P-Lamotr) - \u00dchendlabor","og_description":"Kliinilise keemia ja laboratoorse hematoloogia osakond Lamotrigiin on laia toimespektriga krambivastane ravim, mida kasutatakse partsiaalsete ja generaliseerunud hoogudega epilepsia ning Lennoxi-Gastaut\u2019 s\u00fcndroomiga kaasnevate epileptiliste hoogude ravis. Lamotrigiin on n\u00e4idustatud ka t\u00e4iskasvanute bipolaarse meeleoluh\u00e4ire depressiivse faasi prof\u00fclaktikaks. Suukaudsel manustamisel imendub ravim kiiresti ja praktiliselt t\u00e4ielikult. Maksimaalne kontsentratsioon veres saabub umbes 2\u20133 tunni jooksul p\u00e4rast suukaudset manustamist. [&hellip;]","og_url":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/lamotrigiin-sp-lamotr\/","og_site_name":"\u00dchendlabor","article_modified_time":"2025-12-11T15:29:20+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/lamotrigiin-sp-lamotr\/","url":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/lamotrigiin-sp-lamotr\/","name":"Lamotrigiin (S,P-Lamotr) - \u00dchendlabor","isPartOf":{"@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/#website"},"datePublished":"2025-07-31T13:03:01+00:00","dateModified":"2025-12-11T15:29:20+00:00","breadcrumb":{"@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/lamotrigiin-sp-lamotr\/#breadcrumb"},"inLanguage":"et","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/lamotrigiin-sp-lamotr\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/lamotrigiin-sp-lamotr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.kliinikum.ee\/yhendlabor\/"},{"@type":"ListItem","position":2,"name":"K\u00e4siraamat","item":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/"},{"@type":"ListItem","position":3,"name":"Ravimiseire uuringud","item":"https:\/\/www.kliinikum.ee\/yhendlabor\/kasiraamat\/ravimiseire-uuringud\/"},{"@type":"ListItem","position":4,"name":"Lamotrigiin (S,P-Lamotr)"}]},{"@type":"WebSite","@id":"https:\/\/www.kliinikum.ee\/yhendlabor\/#website","url":"https:\/\/www.kliinikum.ee\/yhendlabor\/","name":"\u00dchendlabor","description":"Hoolivus, Uuendusmeelsus, P\u00e4devus ja Usaldusv\u00e4\u00e4rsus","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.kliinikum.ee\/yhendlabor\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"et"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false},"uagb_author_info":{"display_name":"Kadi Siigur","author_link":"https:\/\/www.kliinikum.ee\/yhendlabor\/author\/kadisi\/"},"uagb_comment_info":0,"uagb_excerpt":"Kliinilise keemia ja laboratoorse hematoloogia osakond Lamotrigiin on laia toimespektriga krambivastane ravim, mida kasutatakse partsiaalsete ja generaliseerunud hoogudega epilepsia ning Lennoxi-Gastaut\u2019 s\u00fcndroomiga kaasnevate epileptiliste hoogude ravis. Lamotrigiin on n\u00e4idustatud ka t\u00e4iskasvanute bipolaarse meeleoluh\u00e4ire depressiivse faasi prof\u00fclaktikaks. Suukaudsel manustamisel imendub ravim kiiresti ja praktiliselt t\u00e4ielikult. Maksimaalne kontsentratsioon veres saabub umbes 2\u20133 tunni jooksul p\u00e4rast suukaudset manustamist.&hellip;","_links":{"self":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/12493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/comments?post=12493"}],"version-history":[{"count":0,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/12493\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/pages\/7301"}],"wp:attachment":[{"href":"https:\/\/www.kliinikum.ee\/yhendlabor\/wp-json\/wp\/v2\/media?parent=12493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}